Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 2019-10-18 20:30
Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products 2019-10-18 10:07
China Biologic Special Committee Retains Financial Advisor and Legal Counsel 2019-10-17 20:00
Envirotainer Opens RAP e2 Station in Liege (LGG) 2019-10-17 14:39
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH 2019-10-16 18:00
Curiox Biosystems Achieves Commercialisation and Fund Raising Success in North Asia with the Support of Cornerstone Investor, ZIG Ventures 2019-10-16 07:00
Movilitas Announces Featured Speakers for Track and Trace Conference in Kuala Lumpur 2019-10-16 04:11
Systech Expands Market-Leading Brand Protection Solution for Improved Supply Chain Visibility 2019-10-15 21:00
Data Presented at 3rd Healthy Lung Summit 2019, Demonstrates Impact of AstraZeneca's Healthy Lung Partnership Programme in 9 Asian Countries 2019-10-15 16:17
Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis 2019-10-15 05:58
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal 2019-10-14 14:00
Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business 2019-10-14 12:51
CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership 2019-10-11 18:00
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. 2019-10-11 13:00
Bayer G4A Partners With Wellthy Therapeutics 2019-10-11 09:00
MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services 2019-10-10 21:00
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors 2019-10-10 15:55
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million 2019-10-09 20:58
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial 2019-10-09 17:56
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots 2019-10-09 12:00
1 304 305 306 307 308 401